Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the field of biopharmaceuticals, supplying promising developments across various health care and industrial apps. With its structural similarity to Normally derived human serum albumin, OsrHSA presents a safer, far more responsible option for therapeutic use, specially in d